Sanofi, GSK to supply COVAX with 200 mn doses of COVID-19 vaccine
New Delhi: Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, ...
Read moreNew Delhi: Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, ...
Read moreLondon: Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX ...
Read moreLondon: Sanofi and GlaxoSmithKline say they are beginning human trials of a potential vaccine for COVID-19 after positive results from ...
Read more